Myongji Hospital
A Da Vinci gastrectomy in the Republic of Korea typically costs from AUD $21,300 to AUD $29,900. Total investment depends on the surgical complexity, the hospital's reputation, and whether a partial or total stomach resection is required. In Australia, this advanced procedure averages AUD $51,900, meaning patients can save approximately 51% by travelling to Seoul. Packages often include the robotic surgery, inpatient hospital stays, and post-operative monitoring.
Bookimed Expert Insight: South Korea leads in gastric cancer outcomes due to immense surgical volumes. Severance Hospital has performed over 4,000 robotic surgeries, providing a level of refinement rarely matched elsewhere. For Australians, the value lies in accessing digital hospital systems like SNUBH's BESTcare. While Gangnam Severance Hospital even offers free transfers for bills over approximately A$6,800, making logistics effortless.
| Republic of Korea | Thailand | Turkey | |
| Da Vinci gastroectomy | ≈ AUD $21,300 | ≈ AUD $22,100 | from AUD $30,600 |
No hidden fees – just official clinic prices. Pay at the clinic for Da Vinci gastroectomy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Da Vinci gastroectomy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Da Vinci gastroectomy journey.
Dr. Kim Taekhyeon is a gastrointestinal surgeon and the Chief of Gastrointestinal Surgery at Naeun Hospital. He received his M.D. and M.S. from Chung-Ang University College of Medicine. He completed an internship at Sungae Hospital and a general surgery residency at Chung-Ang University Hospital. He then finished a fellowship in gastrointestinal surgery at Seoul St. Mary’s Hospital. He previously served as an attending surgeon at Gwangmyeong Sungae Hospital.
His research covers survivin and HSP90 in colorectal cancer, second primary cancers in patients with gastric cancer, and Borrmann type IV gastric carcinoma. He reported outcomes of laparoscopic totally extraperitoneal inguinal hernia repair in 92 cases. His clinical practice includes cancers and diseases of the stomach, esophagus, and small bowel. He also treats hernias, gallstones and cholecystitis, appendicitis, anal disease, varicose veins, and burns.